3 signals · app_store
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Moderate stress signals detected across available public data.
Moderate risk indicators present across data sources.
Limited but mixed signals suggest operational reliability in telehealth services, though external political and regulatory noise may introduce uncertainty.
Signals suggest Ro’s telehealth operations, specifically its refill processes, appear to function reliably, as indicated by consistent on-time refill checks. However, the presence of unrelated political commentary and Roche’s FDA-related announcement—though likely unrelated to Ro—introduces potential noise, complicating a clear assessment. Given the low review volume and sparse coverage, confidence in these observations remains low (18.4/100).
So fast and easy process — I love this app. I was approved and had my first prescription sent to my pharmacy in four days. It’s been 3 months and I’ve lost 28 pounds so far. I only pay $24 for my prescription no matter the dose. The refill check in are always on time and I have never had to wait for my next shot. This is such a convenient option! Thanks Ro!
The refill check in are always on time and I have never had to wait for my next shot.
Ro Khanna Calls for ‘No Aid to Israel,’ Says Next Democratic Administration Must Be ‘Anti-Empire’.
Direct-to-patient healthcare company offering telehealth and pharmacy services.
Based on 3 signals across 1 source · snapshot 25 Aug 2026
Limited: treat this score as early-stage, more data needed.
Overall community sentiment for Ro is negative based on public signals as of 25 Aug 2026.
Limited coverage — score may shift as signals arrive.
Based on 3 signals across 1 source
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
Healthtech / Telehealth industry average
What this means
Limited signals collected so far — this score may shift significantly as more data arrives.
AI-generated from public signals — may be incomplete. Based on 3 recent signals.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.
Basel, 02 June 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the United States (US) Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) under Priority Review for giredestrant, an investigational oral selec…